Pancreatic Cancer Research

ResearcherAl-Azhar UniversityActive in the last 2 years

Ahmed A. El-Husseiny

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0153-6555; OpenAlex author ID A5023161102. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
4
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 3

  1. LncRNA MIR22HG and miR-10a-5p: Pioneering serum biomarkers for pancreatic cancer diagnosis and progression assessment. Last author DOI 10.1016/j.ncrna.2026.04.004↗
  2. The diagnostic value of LncRNA NEAT1 targeting miR-129-5p in pancreatic cancer patients. Last author DOI 10.1038/s41598-025-12963-y↗
  3. Diltiazem potentiates the cytotoxicity of gemcitabine and 5-fluorouracil in PANC-1 human pancreatic cancer cells through inhibition of P-glycoprotein. First author DOI 10.1016/j.lfs.2020.118518↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Rowyda M. Salman · 1 shared paper, 2026 · strength 0.43
  2. Hadeer Saied Mahmoud · 1 shared paper, 2025 · strength 0.37
  3. Ayman M. Gamal El-Din · 1 shared paper, 2020 · strength 0.16
  4. Hesham A. El‐Mahdy · 1 shared paper, 2020 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.